University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Grodno State Medical University, Grodno, Belarus.
University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
J Am Coll Cardiol. 2015 Aug 25;66(8):943-59. doi: 10.1016/j.jacc.2015.06.1313.
Atrial fibrillation (AF) is associated with structural, electrical, and contractile remodeling of the atria. Development and progression of atrial fibrosis is the hallmark of structural remodeling in AF and is considered the substrate for AF perpetuation. In contrast, experimental and clinical data on the effect of ventricular fibrotic processes in the pathogenesis of AF and its complications are controversial. Ventricular fibrosis seems to contribute to abnormalities in cardiac relaxation and contractility and to the development of heart failure, a common finding in AF. Given that AF and heart failure frequently coexist and that both conditions affect patient prognosis, a better understanding of the mutual effect of fibrosis in AF and heart failure is of particular interest. In this review paper, we provide an overview of the general mechanisms of cardiac fibrosis in AF, differences between fibrotic processes in atria and ventricles, and the clinical and prognostic significance of cardiac fibrosis in AF.
心房颤动(AF)与心房的结构、电和收缩重构有关。心房纤维化的发展和进展是 AF 结构重构的标志,被认为是 AF 持续存在的基础。相比之下,关于心室纤维化过程在 AF 发病机制及其并发症中的作用的实验和临床数据存在争议。心室纤维化似乎导致心脏舒张和收缩功能异常,并导致心力衰竭,这是 AF 的常见发现。鉴于 AF 和心力衰竭经常同时存在,并且这两种情况都会影响患者的预后,因此,更好地了解 AF 和心力衰竭中心纤维化的相互作用具有特别的意义。在这篇综述论文中,我们概述了 AF 中心脏纤维化的一般机制、心房和心室纤维化过程之间的差异,以及 AF 中心脏纤维化的临床和预后意义。